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Background. Randomised controlled trials (RCTs) investigating Complementary and Alternative Medicine (CAM) for pregnancy-
related issues have encountered issues with recruitment and attrition. Little is known about the cause of these issues.Methods. Data
was gathered from an antenatal CAM randomised controlled trial. During foetal anomaly appointments, womenmeeting inclusion
criteria were invited to participate in the trial. Numbers of women invited and eligible were recorded. Reasons for noninterest were
noted and analysed. Focus groups exploring trial experience of participants were also conducted. Findings. Of the 428 women
invited to participate, 376 were eligible and just under a quarter participated. Reasons for nonparticipation included concerns
about CAM and lack of interest in participation in research. Other factors negatively affecting recruitment included recruitment
timing, competition for participants, limited support from staff, and inadequate trial promotion. Factors encouraging recruitment
included being interested in research and seeking pain relief. Reasons for dropping out were time constraints, travel issues, work
commitments, and pregnancy issues. Several women in the sham and usual care group dropped out due to dissatisfaction with
treatment allocation. Conclusion. CAM researchers must explore problems encountered with recruitment and attrition so that
evidence-based implementation strategies to address the issues can be developed.
1. Introduction
During pregnancy, women often suffer a range of complaints
such as nausea, vomiting, heartburn, and low back and/or
pelvic pain (LBPP), and many women turn to Comple-
mentary and Alternative Medicine (CAM) to alleviate these
symptoms [1–4]. The percentage of women using CAM
during pregnancy has been reported to be as high as 87%
[5]. However, despite the high percentage of pregnant women
using CAM, there are surprisingly few well-designed ran-
domised controlled trials (RCTs) which have assessed the
effectiveness of CAM interventions during pregnancy and
many of the existing RCTs have encountered difficulties with
recruitment and attrition [6–11].
CAM trials with pregnant women often have small sam-
ple sizes and this is likely related to issues with recruitment.
Mollart [6] recruited just 96 pregnant women during a two-
year period to an RCT investigating the effectiveness of
reflexology for ankle oedema. In addition to this, in a pilot
RCT investigating the effectiveness of chiropractic treatment
and neuroemotional technique compared to exercise for
pregnancy low back pain, researchers recruited just 57 preg-
nant women in 20 months. Kimber et al. [10] took 14 months
to recruit 90 pregnant women to an RCT investigating
massage for labour pain. Small sample sizes such as these
affect the inferential capacity to make firm conclusions on
the effectiveness of these CAM interventions for pregnancy-
related issues. Recruitment of pregnant women into trials
may not be an issue isolated to CAM trials, as other types of
trials with pregnant women have struggled with recruitment.
For example, recruitment rates to dietary and exercise trials
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with pregnant women have been reported to be between 19
and 24% [12–14].
High attrition of study participants has been an issue
that has plagued many CAM trials with pregnant women.
In RCTs, short term attrition rates of greater than 20% are
considered unacceptable and may introduce bias into such
trials [15]. Moreover, attrition rates greater than 30% in a
specific arm of a trial indicate significant flaws exist in the
study and the findings of such studies should be reviewed
and interpreted with caution [15]. Overall attrition rates in
CAM trials with pregnant women frequently exceed 20%.
Kvorning et al. [11] investigated acupuncture for LBPP during
pregnancy and reported an overall dropout rate of 28%. Sim-
ilarly, Lund et al. [7] investigated acupuncture for pelvic pain
in pregnancy and reported an overall dropout rate of 32%.
However, other non-CAM trials with pregnant women have
reported more acceptable overall attrition rates. For example,
in an RCT investigating the effectiveness of the Bellybra
support garment compared to a Tubigrip garment (control)
for pregnancy back pain, attrition was muchmore acceptable
at 18% [16]. Further to overall attrition rates, CAM trials with
pregnant women have also experienced high attrition rates
in comparison groups. For example, Wedenberg et al. [17]
investigated the effectiveness of acupuncture for pregnancy
LBPP compared to physiotherapy. There was a 40% attrition
rate in the physiotherapy group and 0% attrition rate in the
acupuncture group. The difficulty of blinding participants in
CAM trials may be a factor associated with the high attrition
issues discussed [18].
The suboptimal quality of available evidence for CAMuse
during pregnancy is concerning given the high percentage
of pregnant women who report using these treatments.
Therefore, improving the evidence base for CAM use during
pregnancy needs to be prioritised, to equip maternity care
professionals with the knowledge to provide evidence-based
advice and support to pregnant women on the effectiveness
and safety of using CAM interventions during pregnancy. In
order to improve the evidence base for CAM, pressure has
been put on research teams to conductmore RCTs in the area,
as RCTs are recognised as the gold standard for assessing the
effectiveness of interventions [19]. However, the suitability
of using an RCT for assessing the effectiveness of CAM has
been questioned given the many issues CAM RCTs have
been shown to encounter in relation to recruitment, attrition,
blinding, and disagreement on whether CAM treatments
in RCTs should be standardised or should follow a prag-
matic approach as used in clinical practice [20]. However,
despite the questions raised around the suitability of RCTs
to assess CAM effectiveness, it would seem that, given the
current focus on evidence-informed practice, the emphasis
on implementing RCTs to assess CAM effectiveness is set
to continue. Therefore, exploring factors affecting pregnant
women’s participation and dropout in a CAM trial may aid
better recruitment and reduce attrition to such studies in
the future and ultimately may lead to a larger, more robust
evidence base for CAM use during pregnancy which is
desperately lacking.
The evidence base for the effectiveness of reflexol-
ogy in pregnancy is particularly sparse and of dubious
methodological quality. However, reflexology continues to be
offered to pregnant women across the UK within maternity
units and is one of the four most frequently used forms
of CAM in these units [21]. Reflexology is promoted in
these settings for managing a wide range of pregnancy-
related issues including labour preparation and managing
pregnancy-related symptoms such as back and pelvic pain.
Given the use of reflexology in maternity settings in the
absence of any robust evidence of effectiveness for pregnancy-
related complaints, it was deemed important to explore the
effectiveness of reflexology for pregnancy-related issues. The
effectiveness of reflexology for pregnancy low back and pelvic
pain was explored due to the fact that reflexology had been
shown to be helpful for nonspecific low back pain in the
general population [22].
Aim. This paper aims to explore the factors which affect
recruitment and attrition in a pilot RCT investigating reflex-
ology for pregnancy LBPP.
2. Methods
This paper presents secondary data from “The CAM in Preg-
nancy Trial,” (ISRCTN26607527) a pilot RCT investigating
the effectiveness of reflexology for pregnancy LBPP as well
as reporting on the findings from focus groups which were
conducted with The CAM in Pregnancy Trial participants
after their participation in the trial.
2.1. Ethical Approval. This research received full ethical
approval from the Office of Research Ethics for Northern
Ireland in July 2012.
2.2. RCTDescription. Thepilot RCTwas designed and imple-
mented aiming to determine if it was possible to conduct
an RCT investigating the effectiveness of reflexology as an
addition to usual care for pregnancy LBPP.
Women were randomly allocated to one of three groups,
namely, reflexology plus usual care, footbath (as a sham
intervention) plus usual care, or usual care only. Reflexol-
ogy participants received six weeks of reflexology, footbath
participants received six weeks of footbath treatments, and
women in usual care received no additional treatment. The
primary outcome measure was the frequency and intensity
of their pain, which were assessed before and after the six-
week study period. Secondary outcome measures were back
specific function, mobility, and anxiety.
2.3. Midwives Briefing Session. Midwives were acting as
the gatekeepers to the study population; therefore, it was
considered essential that they were given an initial briefing
about the study. In May 2012, a briefing session was given to
the antenatal midwifery team at the maternity unit hosting
the trial. The briefing session aimed to inform midwives
about the trial, its purpose, and the inclusion and exclusion
criteria (Table 1) before the trial began in July 2012. Mid-
wives were provided with a health professional information
sheet detailing information on all aspects of the study, and
additional copies were placed in consultation rooms along
with study posters to prompt midwives to discuss study
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Table 1: Inclusion and exclusion criteria for The CAM in Pregnancy Trial.
Inclusion criteria Exclusion criteria
First-time pregnant women Women pregnant with more than one baby
Being ≥18 years old Smokers
Presence of low back pain and/or pelvic pain Women with neurological diseases
Being in 26–29 weeks of gestation Deep VeinThrombosis (DVT) sufferers
Ability to understand written and verbal English Fungal foot infections or verrucae
Current use of CAM therapies
Placenta Previa grade 3 or grade 4
Already participating in a research study
Any serious spinal pathology, for example, cancer, cauda equina, infection in the
spine
Previous road traffic accident
Previous surgery to the hip, back, or pelvic region
Inflammatory arthritis, for example, rheumatoid arthritis
Diabetes/gestational diabetes
Cardiac related problems
Women whom the midwife deems unable to participate
participation with eligible women. Further to this, as and
when new midwives joined the antenatal midwifery team,
the researchers made efforts to introduce themselves and the
study providing them with a health professional information
sheet.
2.4. Recruitment. Over a 14-month period, pregnant women
were invited to take part in the present trial at a routine
foetal anomaly scan (normally 20–22-week gestation) in a
large urban maternity unit, with approximately 4000 births
annually. As mentioned, antenatal clinic midwives acted
as the gatekeeper for the trial, introducing the study to
potentially eligible pregnant women and asking for women’s
permission for a researcher to provide further verbal and
written information on The CAM in Pregnancy Trial. If
women were happy to receive further information on the
trial from the researcher, the researcher joined the antenatal
appointment. At this point, womenwho expressed an interest
in participationwere providedwith a participant information
sheet. The process of assessing eligibility and randomisation
is described elsewhere [9]. Inclusion and exclusion criteria for
The CAM in Pregnancy Trial are detailed in Table 1.
Women with a DVT, gestational diabetes, or placenta
previa were excluded as complementary therapies are con-
traindicated in several health conditions. Women currently
using CAM therapies were also excluded to remove possible
confounding variables to investigate the effectiveness of
reflexology for pregnancy-related low back and pelvic pain.
2.5. Recruitment Data. The research team gathered data on
the number of women invited to participate and the number
of women eligible. This information was analysed to provide
percentage totals such as the percentage of eligible women
that participated. The research team took written notes on
reasons provided for nonparticipation. These reasons were
compiled and analysed using thematic analysis.
2.6. Attrition Data. Data on attrition rates was generated
from “The CAM in Pregnancy Trial.” Reasons for dropping
out (where provided) were gathered and analysed using
thematic analysis.
2.7. FocusGroups. Focus groupswere conductedwithwomen
who had completed “The CAM in Pregnancy Trial.” The
primary aim of these focus groups was to explore women’s
experience of low back and pelvic pain during pregnancy.
However, a secondary aim of the focus groups was to explore
women’s experience of being part of “The CAM in Pregnancy
Trial.”Womenwere specifically questioned about the positive
and negative aspects of the trial from their perspective. Focus
group findings were analysed using the Newell and Burnard
framework for thematic analysis [23]. Further detail on the
methodology and results from these focus groups is reported
elsewhere [24].
3. Results
3.1. Recruitment. Recruitment took place between July 2012
and September 2013. Of the 428 primigravida women who
were invited to take part in the pilot RCT, 52 did not meet
the inclusion/exclusion criteria identified for this study. The
major factor for exclusion from the pilot RCT was that the
women were already participating in another research study
at that time (𝑛 = 38). This had been identified as exclusion
criteria because participating in two research studies would
have placed additional burden on women, for example, in
terms of their time and travel expenses. After exclusions, this
left 376 potentially eligible women to participate in the pilot
RCT.
Of the eligible women, 70% (𝑛 = 262) expressed an
interest in participating in The CAM in Pregnancy Trial and
therefore were provided with a participant information sheet.
The remaining 30% (𝑛 = 114) of eligible women indicated
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Table 2: Reasons provided for declining invitation to participate in
The CAM in Pregnancy Trial at the point of recruitment.
Reason Number of women (𝑛 = 37)
Not interested in taking part in
research 21 (57%)
Concerned about using CAM in
pregnancy 8 (22%)
Disliking having feet touched 4 (11%)
Travel issues 2 (5%)
Pain so bad and inability to make
weekly appointments for the
study
2 (5%)
from the outset that they did not wish to take part in The
CAM in Pregnancy Trial or receive a participant information
sheet. Of the eligible women who declined to participate
at the point of recruitment, 32% (𝑛 = 37/114) provided
a reason and this was mainly due to a lack of interest in
research (Table 2). Unfortunately, as it was not part of the
study protocol to ask women why they refused to participate
in the trial, we were unable to obtain a reason for refusal to
participate from the remaining 68% (𝑛 = 77/114) of eligible
women who declined the invitation immediately after being
invited to participate.
3.2. Attrition. 64/90 (83%) of women randomised completed
the six-week intervention period. A variety of reasons for
dropping out of the six-week study periodwere provided.The
most common being medical reasons, work commitments,
and being unhappy with treatment allocation. Dropout rates
were the highest in the footbath group and the lowest in the
usual care only group (Table 3).
3.3. Focus Group Findings. The focus groups were attended
by 14 women. Participants had a mean age of 33 and all
had completed the six-week study period of The CAM in
PregnancyTrial; eightwere in the reflexology group, twowere
in the usual care group, and four were in the footbath group.
Most (13/14) of the participants had used CAM previously.
Thematic analysis revealed three major themes in relation to
women’s experiences of the trial, each with two subthemes
(Table 4).
The participant who provided a particular quote in the
focus group will be coded as follows: participant identifica-
tion number, age, and intervention group. The abbreviations
in Table 5 will be used.
3.3.1. Subtheme 1: Factors Negatively Affecting Recruitment
Lack of Awareness and Support for the Trial from Maternity
Staff. Some women identified an issue that health profession-
als did not know that the study was happening and that other
health professionals were not supportive of the trial:
“My own community midwife was like. . .ah. . .I
wish they had of told me about that. . .she was
raging. She said I wish I had been told about
that,” (𝑃𝑁14, 30 𝑅)
“Whenever I was with my midwife they asked
about the sticker on the front of my green
folder and they had never heard of the study
before,” (𝑃𝑁13, 27 𝐹𝐵)
“No offence to some of the midwives and I know
some of them they were a bit blase´ about it (The
CAM in Pregnancy Trial),” (𝑃𝑁3, 34 𝑅)
“I think if that if they (Midwifery staff) were
more. . .mmm more versed or had a wee bit more
knowledge they might be a bit more proactive,”
(𝑃𝑁3, 34 𝑅)
Poor Verbal and Visual Promotion of the Trial.The visual and
verbal promotion of the study may have been a factor for the
slow recruitment to the trial:
“I believe the posters were already up at this
stage but I missed them. . .I must have missed
them. . .they didn’t catch my eye,” (𝑃7, 32 𝑅)
“If there was more detail in the poster,”
(𝑃𝑁3, 34 𝑅)
“It wasn’t mentioned to me, at the 20-week
scan and I mentioned to them about the pelvic
pain,” (𝑃𝑁7, 32 𝑅).
3.3.2. Subtheme 2: Factors Positively Affecting Recruitment
Interested or Experienced in Research. Women reported being
motivated to participate in the trial due to having interest or
experience in research:
“Well I think research is important. . . I would be
interested in research,” (𝑃𝑁2, 32 𝐹𝐵)
“I just thought research is really important. . .
especially if there is loads of people in the future
that it helps. . .I think you have go to start doing
things like that,” (𝑃𝑁4, 30 𝑈𝐶)
“I am a research scientist. . .so I just wanted
to be able to take part. . .to give back in some
way. . .am I appreciate how hard it can be to get
numbers,” (𝑃𝑁7, 32 𝑅).
Desire for SymptomRelief.While somewomen reported being
motivated to participate in the trial for its research potential,
other narratives indicated that the possibility of obtaining
pain relief was the factor whichmotivated their participation.
For some women, it was the nonpharmacological nature of
CAM that attracted them to participate in the trial:
“So as to see if it could be determined if reflexology
was going to help. . .was going to be helpful for
the pelvic pain..there was nothing helping me and
there was nothing else on offer,” (𝑃𝑁11, 36, 𝑈𝐶)
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Table 3: Reasons provided by participants for dropping out of The CAM in Pregnancy Trial.
Reflexology dropouts (𝑛 = 6) Footbath dropouts (𝑛 = 15) Usual care dropouts (𝑛 = 5)
1: preeclampsia
1: travel issues
2: no longer have pain
1: verruca
1: unknown
1: preeclampsia
3: work commitments
3: unhappy with treatment allocation
(wanted reflexology)
1: travel issues
1: personal reasons
1: feeling too tired
5: unknown
1: preeclampsia
1: unhappy with treatment allocation
(wanted reflexology)
3: unknown
Table 4: Themes describing women’s experiences of participating inThe CAM in Pregnancy Trial.
Main theme Subtheme
Factors negatively affecting recruitment (i) Lack of awareness and support for the trial from maternity staff(ii) Poor visual and verbal promotion of the trial
Factors positively affecting recruitment (i) Interested or experienced research(ii) Desire for pain relief
Factors negatively affecting attrition (i) Maternity staff unblinding the trial(ii) Footbath not helping with pain
Table 5: Abbreviations for focus group quotations.
Term Abbreviation
Participant number PN
Reflexology R
Footbath FB
Usual care UC
“It was probably a bit more selfish. . .I would have
taken anything offered to me to be honest. . .I
wasn’t really thinking beyond that,” (𝑃𝑁12, 30, 𝑅)
“I am a great believer in holistic therapies. . .
and I am not a big fan of taking pain killers. . .I
think. . .I will be very honest I had a miscarriage
before I had XXXX and didn’t want to take
any additional medication. . .in case it had an
effect,” (𝑃𝑁3, 34 𝑅)
3.3.3. Subtheme 3: Factors Negatively Affecting Attrition
Maternity Staff Unblinding the Trial. Comments suggested
that unblinding of the active intervention had occurred. In
several instances, the midwife who introduced the study to
them indicated that reflexology was the treatment under
investigation. Women reported on how midwives referred to
the study as a “reflexology study” or “free reflexology”:
“I was told it was free reflexology and that was
how it was sold to me,” (𝑃𝑁10, 34 𝑅 𝐿𝐵𝑃𝑃)
“I think we could have got more information
about each of treatment groups. . .I think I was led
into believing it was reflexology,” (𝑃𝑁9, 35 𝐹𝐵)
“I was told it was reflexology and it would
help your back pain the midwife didn’t actu-
ally say to me at that point there are three
options,” (𝑃𝑁8, 35 𝑈𝐶)
FootbathWas Not Helping Pain.Attrition in the footbath may
have been related to the fact that it was not helping with some
women’s pain:
“I found it relaxing but not for pain,” (𝑃𝑁9,
35 𝐹𝐵)
“I think although it was great to get that time
to myself. . .but it just wasn’t helping my pelvic
pain. . .and the thought of getting in and out
of the car another time each week made me
think what’s the point if it’s not helping my
pain,” (𝑃𝑁2, 32 𝐹𝐵)
4. Discussion
Recruitment was slower than anticipated for The CAM in
Pregnancy Trial given that the trial was recruiting pregnant
women with low back and pelvic pain, conditions highly
prevalent in this population [25]. It was originally anticipated
that recruitment of participants would take approximately
one year. However, due to difficulties identifying suitable
candidates, an additional two months was added to the
recruitment period. Campbell et al. [26] explored rates of
participation in RCTs and found that one-third of RCTs had
to extend the recruitment time-frame to obtain the necessary
sample size.
It is difficult to compare recruitment rates forTheCAM in
Pregnancy Trial and other CAM trials with pregnant women
due to authors failing to report on the numbers of women
invited to participate, the numbers of women assessed for
eligibility, and the numbers of women that participated.
6 Evidence-Based Complementary and Alternative Medicine
There is a tendency in CAM trials to report only on the
numbers of women that actually participated.However, when
comparisons of recruitment rates are made withThe CAM in
Pregnancy Trial and with other CAM studies with pregnant
women that reported detailed recruitment information, it
appears that recruitment to The CAM in Pregnancy Trial
(24%) was within normal ranges. For example, in a three-
armed pilot RCT investigating massage therapy for reducing
pain in labour, researchers recruited 21% of eligible women
[10].
Recruitment rates to The CAM in Pregnancy Trial were
also very similar to other intervention trials with pregnant
women possibly suggesting that recruitment issues expe-
rienced in the present trial may be partly related to the
population under investigation, a population often under-
represented in clinical trials. For example, in an RCT inves-
tigating the effectiveness of a dietary and physical activity
intervention for preventing gestational diabetes, Luoto et
al. [14] recruited 19% of eligible women. Currie et al. [13]
highlighted that pregnant women are a challenging popula-
tion to engage in public health interventions research, with
issues such as work commitments and pregnancy condi-
tions being common reasons for nonparticipation in studies.
Work commitments and pregnancy conditions were issues
in the present study in relation to attrition. Participation
in the present trial initiated from approximately 27 weeks
of gestation, which is the beginning of the third trimester
of pregnancy, a time when pregnant women often suffer
tiredness. Therefore, it is important to implement strategies
where possible to reduce the burden of study participation on
participants, for example, coordinating study appointments
to take place at the same time as antenatal appointments.
The issues identified with recruitment and attrition in the
present trial are a mixture of issues with pregnant women’s
participation in trials in general and pregnant women’s par-
ticipation to CAM trials. For example, recruitment timing is
important for all studies with pregnant women, as insensitive
or untimely invitations to participate in pregnancy trials
may reduce recruitment rates. Recruitment to The CAM
in Pregnancy Trial may have been too early in pregnancy,
with recruitment taking place in the second trimester. LBPP
is more prevalent in the third trimester of pregnancy and
reaches peak intensity and interference at this time [27, 28].
Therefore, trial information provided to women not experi-
encing pain at this time would have been of little relevance
to them. Women’s decision to participate in a clinical trial
during pregnancy is often guided by possible benefits to
maternal and foetal health/well-being, but at 20–22 weeks
manywomen do not have low back or pelvic pain so therefore
there would be little incentive for them to participate [29, 30].
Prompting women again about participation in the study
at an antenatal clinic appointment in the third trimester
could have increased recruitment. Furthermore, recruitment
of participants was at the foetal anomaly scan which may
have been an issue. Some women need to have their foetal
anomaly scan repeated due to the foetus being in a suboptimal
position, which can be distressing. Therefore, these women
may not have taken on board the information on The CAM
in Pregnancy Trial provided at the time.
The recruitment of those not currently using CAM
presents an issue in relation to significantly reducing the pool
of eligible women particularly as CAM treatments are very
popular with pregnant women for managing pain conditions
like pregnancy LBPP [31]. It is highly possible that many
of the women invited to participate may have been using
CAM and thus may not have stepped forward to take part
after being informed by the midwife and/or researcher that
this was an exclusion to trial participation. Furthermore,
the exclusion of current CAM users could be seen as being
possibly bias, as exclusion of current CAM users may have
meant that participants had little knowledge or interest in
CAM. However, in an attempt to minimise this possible bias,
the research team ensured that previousCAMexperiencewas
not exclusion criteria.
Another issue which may affect recruitment of pregnant
women to trials in general is competition for study par-
ticipants from other trials being conducted simultaneously.
The APP trial was also recruiting healthy first-time mothers
at the same time as the present trial but was recruiting
women earlier at their booking appointment at eight—14
weeks of gestation. This meant that, at the recruitment point
for The CAM in Pregnancy Trial, some women were already
participating in the APP trial which reduced the number
of eligible participants. Competition for participants has
previously been reported as a barrier to effective recruitment
into research studies [32, 33]. Better planning of recruitment
timing and the use of a multicentred approach to recruitment
may have improved recruitment rates of the trial.
Focus groupfindings indicated that not all eligiblewomen
were informed about the study indicating that discussions
about the trial with eligible women were ad hoc. The
reasons why midwives did not inform all eligible women
about the study are unclear. Nonrecruitment of potentially
eligible women by gatekeepers such as maternity health
professionals would appear to be an issue more generally
for trials with pregnant women. Research has shown that
these health professionals frequently report lack of time,
lack of awareness of ongoing trials, and lack of knowledge
of trial inclusion criteria as reasons for nonrecruitment of
pregnant women into research studies [32–35]. Midwives
often change department in maternity units and so newer
midwives to departments where trials are being conducted
may not be aware that studies are taking place. This may
be due to their absence at study information sessions or
due to study information being put in inaccessible locations,
for example, under other paperwork as identified by Stuart
et al. [34, 35]. This also happened in the current study
where trial information sheets for health professionals were
put in a locked cabinet and so were not easily accessible
to staff. Maternity staff may need regular briefing sessions
about ongoing research projects to ensure that all staff,
including those new to the department, are fully aware
of current studies and their inclusion/exclusion criteria.
Regular briefing sessions may also provide an opportunity
for researchers to provide details on recruitment rates which
may encourage staff to be more proactive with introducing
the study to eligible women. Focus group comments from
women also suggested that there was a lack of support from
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somemidwifery staff when womenmentioned that they were
taking part in The CAM in Pregnancy Trial. Provision of
regular briefing sessions onCAM trials with pregnant women
tomaternity professionals may be of even greater importance
than other trials with pregnant women given that midwives
attitudes towards CAMuse in pregnancy can vary from some
midwives being overenthusiastic about its benefits to others
being totally dismissive of its potential for effectiveness [21,
36]. Therefore, it is possible that midwives owning personal
attitudes towards CAMmay have affected recruitment rates.
Another issue which may have affected recruitment was
the visual promotion of the trial; and this may be an issue
for poor recruitment rates to pregnancy trials in general.
Women discussed during the focus group how they did
not see the poster in the hospital and others thought that
the poster did not give an accurate reflection of what the
pilot RCT involved. During The CAM in Pregnancy Trial,
only one A3 poster advertising the study was on display
for most of the 14-month recruitment period. Originally,
there were 12 study posters on display throughout the
antenatal clinic waiting area but for unknown reasons an
obstetrician removed all but one poster shortly after the trial
began recruiting. It could be speculated that this may be
related to the personal views of this obstetrician. Research
with maternity professionals has shown that midwives and
obstetricians have contrasting opinions on the effectiveness
of CAM [37]. A survey by Gaffney and Smith [37] reported
that 88 (65%) midwives agreed that alternative therapies are
effective in encouraging the body’s natural healing ability, yet
only 13 (19%) obstetricians agreedwith this statement and few
would recommend CAM. In contrast to this, obstetricians
appear more supportive of medications during pregnancy as
opposed to alternative medicines for pain. For example, a
survey of obstetricians found that 80% felt paracetamol was
appropriate to recommend during pregnancy for dental pain
[38]. Better use of social media such as Facebook and Twitter
may have been useful for increasing recruitment rates. Shere
et al. [39] found that the addition of these forms of social
media increased recruitment of pregnantwomen into anRCT
investigating folic acid by 12-fold compared to traditional
sources of promotion such as posters, leaflets, and brochures.
A specific issue related to recruiting pregnant women
to CAM trials is “safety concerns,” which is understandable
given that the majority of CAM is not provided by the NHS
but rather is available fromprivate individuals/ organisations,
which may make pregnant women dubious about accessing
such treatments if they are not providedwithin routine health
service provision [40]. Tooher et al. [32, 33] suggest that per-
ception of risk is an important issue when pregnant women
aremaking decisions about trial participation. If the pregnant
women’s perception of risk is too high, they will ultimately
refuse to take part in an RCT [29]. Research has shown that
pregnant women generally put more priority on the health
of their baby rather than their own health [30]. While only
eight women actually reported concern about the safety of
reflexology during pregnancy as a reason for declining the
invite to participate in the present trial; many other women
questioned the researchers at the initial recruitment about the
safety of reflexology in relation to its ability to induce labour.
Concerns about reflexology are unsurprising given the lack
of clarity about the role of reflexology in labour induction
and the fact that midwives recommend the use of reflexology
for induction of labour [41, 42]. In these circumstances, it
is important that maternity staff make it clear to women
that there is no sound scientific evidence that reflexology
stimulates labour and that the few studies that have found an
impact of reflexology on expediting labour are of low quality
and employed specific reflexology techniques which would
never be performed in studies assessing reflexology for other
pregnancy-related issues.
During recruitment, it was observed that women fre-
quently looked towards the midwife for reassurance that
reflexology was safe to use during pregnancy. The level of
reassurance provided by midwives in these instances varied.
Women’s concerns about using reflexology during pregnancy
along with limited reassurance about the safety of using
reflexology during pregnancy from some midwives could
have been a contributory factor in the slow recruitment rates.
Adopting a universal phrase about the safety of CAM in
the pregnant population may have been helpful for ensuring
women’s confidence in participation in a CAM trial. Indeed,
several RCTs investigating reflexology have been conducted
on pregnant populations and no adverse effects have been
reported. Maternity professionals must draw on high quality
RCT or systematic review evidence (if available) when pro-
viding a statement about the safety of reflexology or other
CAM treatments if questioned by prospective CAM trial
participants [41–43].
In spite of the fact that some of the findings of this paper
are focused on factors which negatively affect recruitment
of pregnant women into trials, there were some findings
from focus groups which highlighted factors which may pos-
itively facilitate recruitment into a CAM trials with pregnant
women. These included desire for pain relief in general and
specifically pain relief that was nonpharmacological. These
findings concur with research conducted by Mohanna [30]
who explored decision-making processes of pregnant women
regarding participation in trials and also research by Wang
et al. [31] who explored women’s preferences regarding treat-
ment for pregnancy low back pain. Researchers recruiting
pregnant women into CAM trials may wish to make it clear
that CAM is a nonpharmacological treatment as well as
referring to available evidence related to its effectiveness and
safety for pregnancy-related symptoms for conditions like
pregnancy LBPP.
Attrition rates in the sham group were another major
issue in The CAM in Pregnancy Trial, with a 50% attrition
rate in this group. High attrition rates in the footbath group
indicate significant flaws in the study design [12]. The high
attrition ratesmay be explained bywomen’s reported hopes of
getting randomised to the reflexology group. Several women
in the usual care and footbath groups reported that the
reason why they dropped out of the trial was that they had
not been randomised to receive reflexology. Attrition rates
have been found to be problematic in previous CAM trials
with pregnant women. Mollart [6] had similar issues with
dropouts in a single blind RCT investigating the effectiveness
of two types of reflexology for ankle oedema compared
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with a control group who received no reflexology but were
rather instructed to rest on an examination couch for the
same length of time as reflexology treatments. Seven of the
69 women randomised to the rest control group dropped
out immediately after randomisation, three of whom stated
their reason for dropping out was that “rest doesn’t work”.
The possible reason for high attrition rates in the present
study and other similar CAM trials may be due to blinding
issues. If participants are aware of which treatment is the
treatment of interest for the study, it is understandable
that many would not wish to continue with the study if
they realise that they have been randomised to a sham
intervention.
Blinding in the present study may not have been suc-
cessful inmany instances.Women’s comments suggested that
they knew that reflexology was the treatment of interest.
The unblinding of the study by midwives is understandable
as reflexology is one of the CAM therapies most frequently
offered in maternity units in the UK [21]. Furthermore,
some of midwives in the antenatal clinic where The CAM
in Pregnancy Trial was conducted were reflexology-trained
themselves and it is probable that these midwives may
have been overenthusiastic about the reflexology aspect of
the research, inadvertently placing more emphasis on the
reflexology when introducing the research to women.
4.1. Limitations. Only a small number of the women invited
to participate in The CAM in Pregnancy Trial actually
provided reasons for refusing to take part which reduces the
external validity of the current results.Thiswas a limitation in
the research design as it was not part of the study protocol to
askwomen for a reason for their nonparticipation and as such
the women who provided reasons for nonparticipation may
differ from those who did not, thus raising questions about
the representativeness of the sample.
5. Conclusion
General barriers identified to pregnant women’s participation
in trials included timing of recruitment, competition for par-
ticipants from other trials, and inadequate trial promotion.
Specific barriers to pregnant women’s participation in CAM
trials includedwomen’s perception of the risk of participation
and limited support for maternity staff. Poor study blinding
was likely to be the major reason for the high attrition rates
for the sham treatment group in the present trial. Researchers
wishing to recruit pregnant women to trials and specifically
CAM trials need to consider the barriers to recruitment and
factors associated with high attrition identified in the present
study and identify appropriate strategies to overcome these
commonly occurring issues in CAM trials with pregnant
women. Otherwise, CAM trials with pregnant women will
continue to be of poor quality and the evidence base for CAM
during pregnancy will remain suboptimal.
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